IL144583A0 - Chimeric protein kinase inhibitors - Google Patents
Chimeric protein kinase inhibitorsInfo
- Publication number
- IL144583A0 IL144583A0 IL14458301A IL14458301A IL144583A0 IL 144583 A0 IL144583 A0 IL 144583A0 IL 14458301 A IL14458301 A IL 14458301A IL 14458301 A IL14458301 A IL 14458301A IL 144583 A0 IL144583 A0 IL 144583A0
- Authority
- IL
- Israel
- Prior art keywords
- protein kinase
- kinase inhibitors
- chimeric protein
- chimeric
- inhibitors
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Diabetes (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Immunology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Epidemiology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Neurology (AREA)
- Child & Adolescent Psychology (AREA)
- Biomedical Technology (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Priority Applications (9)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IL14458301A IL144583A0 (en) | 2001-07-26 | 2001-07-26 | Chimeric protein kinase inhibitors |
NZ531120A NZ531120A (en) | 2001-07-26 | 2002-07-25 | Protein kinase inhibitors comprising ATP mimetics conjugated to peptides or peptidomimetics |
EP02751604A EP1416934A4 (fr) | 2001-07-26 | 2002-07-25 | Inhibiteurs de proteine kinase comprenant des mimetiques de atp conjugues a des peptides ou a des peptidomimetiques |
JP2003515632A JP2005501047A (ja) | 2001-07-26 | 2002-07-25 | ペプチド又はペプチド模倣物質と結合したatp模倣物質を含むプロテインキナーゼ阻害剤 |
AU2002355204A AU2002355204B2 (en) | 2001-07-26 | 2002-07-25 | Protein kinase inhibitors comprising ATP mimetics conjugated to peptides or peptidomimetics |
CA002455602A CA2455602A1 (fr) | 2001-07-26 | 2002-07-25 | Inhibiteurs de proteine kinase comprenant des mimetiques de atp conjugues a des peptides ou a des peptidomimetiques |
PCT/IL2002/000618 WO2003010281A2 (fr) | 2001-07-26 | 2002-07-25 | Inhibiteurs de proteine kinase comprenant des mimetiques de atp conjugues a des peptides ou a des peptidomimetiques |
US10/764,288 US7407939B2 (en) | 2001-07-26 | 2004-01-23 | Protein kinase inhibitors comprising ATP mimetics conjugated to peptides or peptidomimetics |
US11/862,542 US20080070843A1 (en) | 2001-07-26 | 2007-09-27 | Protein kinase inhibitors comprising atp mimetics conjugated to peptides or peptidomimetics |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IL14458301A IL144583A0 (en) | 2001-07-26 | 2001-07-26 | Chimeric protein kinase inhibitors |
Publications (1)
Publication Number | Publication Date |
---|---|
IL144583A0 true IL144583A0 (en) | 2002-05-23 |
Family
ID=11075649
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL14458301A IL144583A0 (en) | 2001-07-26 | 2001-07-26 | Chimeric protein kinase inhibitors |
Country Status (8)
Country | Link |
---|---|
US (2) | US7407939B2 (fr) |
EP (1) | EP1416934A4 (fr) |
JP (1) | JP2005501047A (fr) |
AU (1) | AU2002355204B2 (fr) |
CA (1) | CA2455602A1 (fr) |
IL (1) | IL144583A0 (fr) |
NZ (1) | NZ531120A (fr) |
WO (1) | WO2003010281A2 (fr) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL144583A0 (en) | 2001-07-26 | 2002-05-23 | Peptor Ltd | Chimeric protein kinase inhibitors |
IL156429A0 (en) * | 2003-06-12 | 2004-01-04 | Peptor Ltd | Cell permeable conjugates of peptides for inhibition of protein kinases |
US20050004038A1 (en) * | 2003-06-27 | 2005-01-06 | Lyon Robert P. | Bivalent inhibitors of Glutathione-S-Transferases |
WO2006108270A1 (fr) | 2005-04-11 | 2006-10-19 | Pharmagap Inc. | Inhibiteurs de proteines kinases et leurs utilisations |
EP1922086A4 (fr) * | 2005-08-05 | 2011-08-03 | Pharmagap Inc | Inhibiteurs de protéine kinase c ciblés et leurs utilisations |
EE200600030A (et) * | 2006-08-15 | 2008-04-15 | Tartu �likool | Proteiinkinaasi fluorestsents-sond |
WO2008070823A2 (fr) | 2006-12-07 | 2008-06-12 | University Of South Florida | Inhibiteur d'akt mimant le substrat |
US8431529B2 (en) * | 2007-07-31 | 2013-04-30 | Sanford-Burnham Medical Research Institute | Bi-dentate compounds as kinase inhibitors |
BRPI0918970A2 (pt) * | 2008-09-05 | 2019-09-24 | Avila Therapeutics Inc | algoritmo para projeto de inibidores irreversíveis |
JP5364847B2 (ja) * | 2009-09-03 | 2013-12-11 | グラダリス インク. | 組織特異的なペプチド模倣リガンドを用いる標的化送達 |
BR112012005962A8 (pt) * | 2009-09-16 | 2018-01-02 | Avila Therapeutics Inc | Conjugados de proteína quinase, compostos e composição farmacêutica compreendendo os referidos compostos |
WO2011082285A1 (fr) | 2009-12-30 | 2011-07-07 | Avila Therapeutics, Inc. | Modification covalente de protéine, dirigée sur un ligand |
US11162083B2 (en) | 2018-06-14 | 2021-11-02 | University Of South Carolina | Peptide based inhibitors of Raf kinase protein dimerization and kinase activity |
KR102152977B1 (ko) * | 2018-08-29 | 2020-09-07 | 충남대학교 산학협력단 | 암 예방 또는 치료용 펩타이드 및 이를 포함하는 약학적 조성물 |
JP7385191B2 (ja) * | 2019-08-30 | 2023-11-22 | 学校法人同志社 | Eml4-alk阻害ペプチドおよびこれを含む肺がん治療薬 |
Family Cites Families (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2163904C (fr) | 1993-05-28 | 2000-01-25 | Craig A. Dionne | Utilisation de derives de l'indolocarbazole pour traiter un etat pathologique de la prostate |
US5594090A (en) | 1994-04-06 | 1997-01-14 | Nof Corporation | Alkylene sulfide group-containing prepolymer, polymerizable composition and optical material |
US5475110A (en) | 1994-10-14 | 1995-12-12 | Cephalon, Inc. | Fused Pyrrolocarbazoles |
US5591855A (en) | 1994-10-14 | 1997-01-07 | Cephalon, Inc. | Fused pyrrolocarbazoles |
US5705511A (en) | 1994-10-14 | 1998-01-06 | Cephalon, Inc. | Fused pyrrolocarbazoles |
US5650407A (en) | 1995-04-05 | 1997-07-22 | Cephalon, Inc. | Selected soluble esters of hydroxyl-containing indolocarbazoles |
WO1997022360A2 (fr) * | 1995-12-20 | 1997-06-26 | Medical Research Council | Regulation de synthese de proteines et procede de criblage pour agents pharmaceutiques |
US20020065221A1 (en) | 1995-12-20 | 2002-05-30 | Philip Cohen | Control of protein synthesis, and screening method for agents |
US20050053594A1 (en) | 1995-11-16 | 2005-03-10 | Dario Alessi | RAC-PK as a therapeutic agent or in diagnostics, screening method for agents and process for activating RAC-PK |
SE9600769D0 (sv) * | 1996-02-28 | 1996-02-28 | Astra Ab | Compounds useful as analgesic |
US7037891B2 (en) | 1997-05-21 | 2006-05-02 | Children's Medical Center Corporation | Methods of modulating G-protein-coupled receptor kinase-associated signal transduction |
US6174993B1 (en) | 1997-05-21 | 2001-01-16 | The Children's Medical Center Corp. | Short peptides which selectively modulate the activity of serine/threonine kinases |
WO1999008668A2 (fr) | 1997-08-15 | 1999-02-25 | Cephalon, Inc. | Inhibiteur de tyrosine kinase combine a une castration chimique pour traiter un cancer de la prostate |
US6087350A (en) | 1997-08-29 | 2000-07-11 | University Of Pittsburgh Of The Commonwealth System Of Higher Education | Use of pretreatment chemicals to enhance efficacy of cytotoxic agents |
US6703381B1 (en) | 1998-08-14 | 2004-03-09 | Nobex Corporation | Methods for delivery therapeutic compounds across the blood-brain barrier |
US6528486B1 (en) | 1999-07-12 | 2003-03-04 | Zealand Pharma A/S | Peptide agonists of GLP-1 activity |
JP2001247459A (ja) | 2000-03-03 | 2001-09-11 | Oakland Uniservices Ltd | 癌の組み合わせ療法 |
AU4587901A (en) | 2000-03-21 | 2001-10-03 | Univ Johns Hopkins | Bisubstrate inhibitors of kinases |
IL152807A0 (en) * | 2000-05-30 | 2003-06-24 | Peptor Ltd | Protein kinase inhibitors |
US7034026B2 (en) | 2001-04-10 | 2006-04-25 | Merck & Co., Inc. | Inhibitors of Akt activity |
IL144583A0 (en) | 2001-07-26 | 2002-05-23 | Peptor Ltd | Chimeric protein kinase inhibitors |
CA2471385A1 (fr) | 2001-12-27 | 2003-07-10 | Takeda Chemical Industries, Ltd. | Medicaments pour la prevention et le traitement du cancer |
AU2003226301A1 (en) | 2002-04-08 | 2003-10-20 | Merck And Co., Inc. | Method of treating cancer |
AU2002364707A1 (en) | 2002-04-23 | 2003-11-10 | Duke University | Atherosclerotic phenotype determinative genes and methods for using the same |
IL156429A0 (en) | 2003-06-12 | 2004-01-04 | Peptor Ltd | Cell permeable conjugates of peptides for inhibition of protein kinases |
-
2001
- 2001-07-26 IL IL14458301A patent/IL144583A0/xx unknown
-
2002
- 2002-07-25 AU AU2002355204A patent/AU2002355204B2/en not_active Ceased
- 2002-07-25 EP EP02751604A patent/EP1416934A4/fr not_active Withdrawn
- 2002-07-25 JP JP2003515632A patent/JP2005501047A/ja active Pending
- 2002-07-25 WO PCT/IL2002/000618 patent/WO2003010281A2/fr active Application Filing
- 2002-07-25 CA CA002455602A patent/CA2455602A1/fr not_active Abandoned
- 2002-07-25 NZ NZ531120A patent/NZ531120A/en unknown
-
2004
- 2004-01-23 US US10/764,288 patent/US7407939B2/en not_active Expired - Fee Related
-
2007
- 2007-09-27 US US11/862,542 patent/US20080070843A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO2003010281A3 (fr) | 2003-11-13 |
US20050026840A1 (en) | 2005-02-03 |
US7407939B2 (en) | 2008-08-05 |
EP1416934A4 (fr) | 2005-11-02 |
CA2455602A1 (fr) | 2003-02-06 |
AU2002355204B8 (en) | 2003-02-17 |
JP2005501047A (ja) | 2005-01-13 |
US20080070843A1 (en) | 2008-03-20 |
WO2003010281A2 (fr) | 2003-02-06 |
NZ531120A (en) | 2008-03-28 |
AU2002355204B2 (en) | 2007-08-16 |
EP1416934A2 (fr) | 2004-05-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUP0400300A2 (en) | Pyrrolopyrimidines as protein kinase inhibitors | |
HK1068134A1 (en) | Pyrrolopyrimidines as protein kinase inhibitors | |
HK1062433A1 (en) | Pyrazole compounds useful as protein kinase inhibitors | |
HK1057748A1 (en) | Pyrazole compounds useful as protein kinase inhibitors | |
IL161516A0 (en) | Benzimidazoles useful as protein kinase inhibitors | |
IL144583A0 (en) | Chimeric protein kinase inhibitors | |
SI1318997T1 (sl) | Pirazolne spojine, uporabne kot inhibitorji protein-kinaze | |
IL145329A0 (en) | Protein tyrosine kinase inhibitors | |
IL151779A0 (en) | Protein tyrosine kinase inhibitors | |
SI1345922T1 (sl) | Pirazolne spojine, koristne kot inhibitorji protein kinaze | |
AU2002355906A1 (en) | Thiopyrane-4-ones as dna protein kinase inhibitors |